Recent Insider Transactions - Intellia Therapeutics (NASDAQ: NTLA)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ NTLA Intellia Therapeutics

Dube Michael P / officer: VP, Chief Accounting Officer

01/03/2025

Sell

$12.18

1,372

$17K

45,640

NASDAQ NTLA Intellia Therapeutics

BASTA JAMES / officer: EVP, General Counsel

01/03/2025

Sell

$12.18

7,074

$86K

74,497

NASDAQ NTLA Intellia Therapeutics

Lebwohl David / officer: EVP, Chief Medical Officer

01/03/2025

Sell

$12.18

9,557

$116K

87,666

NASDAQ NTLA Intellia Therapeutics

Hicks Derek / officer: EVP, Chief Business Officer

01/03/2025

Sell

$12.18

6,502

$79K

59,878

NASDAQ NTLA Intellia Therapeutics

LEONARD JOHN M / director, officer: President and CEO

01/03/2025

Sell

$12.18

26,807

$327K

941,115

NASDAQ NTLA Intellia Therapeutics

Sepp-Lorenzino Laura / officer: EVP, Chief Scientific Officer

01/03/2025

Sell

$12.18

8,966

$109K

77,388

NASDAQ NTLA Intellia Therapeutics

Clark Eliana / officer: EVP, Chief Technical Officer

01/02/2025

Sell

$12.03

556

$7K

71,470

NASDAQ NTLA Intellia Therapeutics

Clark Eliana / officer: EVP, Chief Technical Officer

01/03/2025

Sell

$12.18

7,422

$90K

64,048